EyePoint Pharmaceuticals
EyePoint Pharmaceuticals Logo
About EyePoint Pharmaceuticals
EyePoint Pharmaceuticals Inc is a biopharmaceutical company focused on developing and commercializing innovative therapeutics to treat serious retinal diseases. Utilizing its proprietary Durasert E technology for sustained intraocular drug delivery, the company’s lead product candidate, DURAVYU, is an investigational treatment for VEGF-mediated retinal diseases such as wet age-related macular degeneration, non-proliferative diabetic retinopathy, and diabetic macular edema. EyePoint’s pipeline also includes EYP-2301, a TIE-2 agonist in pre-clinical development for retinal conditions. The company serves patients worldwide.
Address
480 Pleasant Street, Suite A-210
Watertown, 02472
United States
Year founded
2008
Number of employees
100-200
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
